Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMMX

Immix Biopharma Inc

May 29 • 04:00PM ET

9.00

+0.16 1.81 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY KYMR NUVL BMRN RYTM VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC AVSC TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	24.07%	Shs Outstand	53.01M	Perf Week	3.81%
Market Cap	489.70M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	0.01%	Shs Float	41.32M	Perf Month	4.29%
Enterprise Value	400.16M	PEG	-	EPS next Q	-0.18	Inst Own	49.02%	Short Float	7.79%	Perf Quarter	11.52%
Income	-34.98M	P/S	-	EPS this Y	21.53%	Inst Trans	3.81%	Short Ratio	3.40	Perf Half Y	109.30%
Sales	0.00M	P/B	5.66	EPS next Y	7.28%	ROA	-60.47%	Short Interest	3.22M	Perf YTD	72.08%
Book/sh	1.59	P/C	5.41	EPS next 5Y	39.20%	ROE	-74.47%	52W High	11.61 -22.48%	Perf Year	300.00%
Cash/sh	1.66	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.87 381.28%	Perf 3Y	414.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.35% 8.27%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.75	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.17	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	-4.62%	Beta	0.10	Target Price	18.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-3.62%	Rel Volume	1.02	Prev Close	8.84
Employees	21	LT Debt/Eq	0.01	Earnings	Feb 25	SMA200	53.58%	Avg Volume	947.46K	Price	9.00
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-83.03% -	Trades		Volume	963,861	Change	1.81%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)